SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-24-061079
Filing Date
2024-05-16
Accepted
2024-05-16 16:09:00
Documents
11
Period of Report
2024-04-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A prld-20240408.htm   iXBRL 8-K/A 44301
  Complete submission text file 0000950170-24-061079.txt   187679

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT prld-20240408.xsd EX-101.SCH 46367
14 EXTRACTED XBRL INSTANCE DOCUMENT prld-20240408_htm.xml XML 5549
Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39527 | Film No.: 24955588
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)